Yield10 Bioscience, Inc. Common Stock
YTEN
YTEN was delisted on the 15th of May, 2024.
12 hedge funds and large institutions have $1.51M invested in Yield10 Bioscience, Inc. Common Stock in 2023 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 1 closing their positions.
200% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 1
20% more funds holding
Funds holding: 10 → 12 (+2)
13% more capital invested
Capital invested by funds: $1.34M → $1.51M (+$172K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Armistice Capital
New York
|
+$586K |
| 2 |
VCM
Vigilant Capital Management
Portland,
Maine
|
+$10.9K |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
+$6.18K |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$3.84K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GWM
Grand Wealth Management
Grand Rapids,
Michigan
|
-$78.1K |
| 2 |
TWA
TCI Wealth Advisors
Tucson,
Arizona
|
-$9 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
CC
1
Cannell & Co
New York
| $575K | – | – | – |
|
|
AC
2
Armistice Capital
New York
| $480K | +$586K | +9,000 | New |
|
3
Vanguard Group
Malvern,
Pennsylvania
| $237K | – | – | – |
|
4
Geode Capital Management
Boston,
Massachusetts
| $77.4K | – | – | – |
|
5
BlackRock
New York
| $69.7K | – | – | – |
|
|
BC
6
Birchview Capital
Burlington,
Vermont
| $41.6K | – | – | – |
|
|
TRCT
7
Tower Research Capital (TRC)
New York
| $10.9K | +$6.18K | +95 | +86% |
|
|
VCM
8
Vigilant Capital Management
Portland,
Maine
| $9K | +$10.9K | +167 | New |
|
|
CWP
9
Concord Wealth Partners
Abingdon,
Virginia
| $7.77K | – | – | – |
|
|
10
Fidelity Investments
Boston,
Massachusetts
| $3.12K | +$3.84K | +59 | New |
|
11
Wells Fargo
San Francisco,
California
| $78 | – | – | – |
|
|
IA
12
IFP Advisors
Tampa,
Florida
| $67 | – | – | – |
|
|
SIC
13
Salem Investment Counselors
Winston Salem,
North Carolina
| $3 | – | – | – |
|
14
Morgan Stanley
New York
| $2 | – | – | – |
|
|
GWM
15
Grand Wealth Management
Grand Rapids,
Michigan
| – | -$78.1K | -1,178 | Closed |
|
|
TWA
16
TCI Wealth Advisors
Tucson,
Arizona
| – | -$9 | – | – |
|
YTEN Hedge Fund Activity: Q2 2023 in Review
12 of the 6,370 institutional investors tracked by Wall St. Rank reported a position in Yield10 Bioscience, Inc. Common Stock (YTEN) for Q2 2023, worth a combined $1.51M — up 13% from $1.34M a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new YTEN positions and 1 closed out — a net gain of 2 holders — while 1 added to existing stakes and 0 trimmed.
The largest buyer was Armistice Capital, opening a new position worth an estimated $586K. The largest seller was Grand Wealth Management, exiting entirely with an estimated $78.1K sold.
- 12 institutional investors held Yield10 Bioscience, Inc. Common Stock (YTEN) as of Q2 2023, up from 10 in Q1 2023.
- Funds reported $1.51M of Yield10 Bioscience, Inc. Common Stock stock for Q2 2023, up 13% quarter-over-quarter.
- 3 funds opened new Yield10 Bioscience, Inc. Common Stock positions in Q2 2023 and 1 closed out, a net change of +2 holders.
- The largest Yield10 Bioscience, Inc. Common Stock buyer in Q2 2023 was Armistice Capital, an estimated $586K added.
- The largest Yield10 Bioscience, Inc. Common Stock seller in Q2 2023 was Grand Wealth Management, an estimated $78.1K sold.
Based on aggregated 13F filings for Q2 2023.